A. Thoelke

The influence of maternal exposure to volatile organic compounds on the cytokine secretion profile of neonatal T cells

Irina Lehmann, A. Thoelke, M. Rehwagen et al. · Environmental Toxicology · 2002 · 131 citations

Life Sciences, Child Health, Immunology +17

<i>In vitro</i> Drug Sensitivity Predicts Response and Survival after Individualized Sensitivity-Directed Chemotherapy in Metastatic Melanoma: A Multicenter Phase II Trial of the Dermatologic Cooperative Oncology Group

Selma Ugurel, Dirk Schadendorf, Claudia Pföhler et al. · Clinical Cancer Research · 2006 · 88 citations · Full text

Medicine, Oncology, Pharmacology +12

Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study

Dirk Schadendorf, Axel Hauschild, Selma Ugurel et al. · Annals of Oncology · 2006 · 51 citations · Full text

Medicine, Neurology, Oncology +13

T cell reactivity in neonates from an East and a West German city – results of the LISA study

Irina Lehmann, A. Thoelke, Uwe Schlink et al. · Allergy · 2002 · 49 citations

Life Sciences, Child Health, Immunology +16

Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma

M. Şahin Uğurel, Dirk Schadendorf, Wolfram Fink et al. · Oncology Research and Treatment · 2004 · 36 citations

Medicine, Oncology, Pharmacology +17